Five Digital Health Trends for 2024
by Ana Díaz-Roncero, January 10, 2024
Over the past few years, we have experienced major changes in the healthcare environment, specifically in the development and implementation of various Digital Health solutions that are demonstrating promising results in the research and treatment of diseases. Among these advances, there are some that have come to stay and in 2024 we will see them gain traction and take center stage:
- Artificial Intelligence (AI)
In 2023, Artificial Intelligence (AI) was part of a paradigm shift in the way we understand the world. In healthcare, specifically, it is being applied in prevention, treatment, and research into diseases and medications, and it is expected that its use will continue expanding in 2024 with various goals from improving healthcare by using chatbots to the optimization of patient flow.
In addition, AI will make research more efficient, streamlining the development of medications and treatments, as well as facilitating the implementation of personalized medicine.
Because of this, it is expected that the market for healthcare tools based on AI will exceed $34 billion in 2025.
- Personalized medicine
Personalized medicine consists of providing treatments that are adapted to the unique needs of each patient, with the goal of improving the effectiveness of therapies, reducing secondary effects, and improving the patient’s quality of life. This focus will be a trend in 2024 thanks to advances in genomics, big data, and artificial intelligence. This was anticipated by the “Global Personalized Medicine Market Analysis & Trends” article, which suggested that the market for personalized medicine could reach $233.4 billion in 2025.
- Remote patient monitoring and telemedicine
Remote patient monitoring and telemedicine are trends that were maintained throughout the pandemic, and will continue playing a key role in 2024, helping carry out remote patient monitoring in real time, avoiding unnecessary visits to the healthcare centers. Remote patient monitoring platforms will be supported by the increase in the use of wearables and health apps, which will enable the European market for these platforms to grow a 6% annually through 2027.
In addition, these platforms will be complemented by telemedicine services, improving waiting times, the efficiency of healthcare, access to medical services in rural areas, and minimizing the risk of exposure to infection.
- Digital Therapeutics (DTx)
Digital Therapeutics are evidence-based software that can be used independently or together with a therapy, with the goal of preventing, managing, and treating diseases.
During 2023, we saw how these tools began to emerge in the management of diseases, providing solutions capable of improving patient outcomes. Because of this, the market is growing significantly, from $9 billion in 2020 to a predicted $56 billion in 2025, as we noted in “The promising sector of Digital Therapeutics (DTx)”.
This trend is expected to continue growing in 2024, as various countries are beginning to develop specific regulations to manage and reimburse these digital solutions, as is the case in Germany, Belgium, France, and other countries.
In a healthcare environment that is increasingly digital, the interoperability of different healthcare software will be essential in 2024 to improve the patient’s experience and achieve more efficient care. Specifically, the integration of in-person and virtual care will be crucial, as indicated in the report, “Future Health Index 2023”, where this kind of integration is pointed out as one of the primary factors of success when offering new forms of care.
In conclusion, 2024 promises to be an exciting year in the environment of Digital Health, where the convergence of technology and medicine will continue to redefine healthcare. At Persei vivarium, we are aware of this, and participating in the challenges that need to be addressed in healthcare. Therefore, our goal is to offer complete solutions that include these trends and meet the current needs of healthcare professionals, industry, and patients.